Services
GENE AND CELL THERAPY

GENE AND CELL THERAPY

Tailored product development Details

ANALYTICAL DEVELOPMENT AND QUALITY CONTROL

ANALYTICAL DEVELOPMENT AND QUALITY CONTROL

High-efficient, High-quality Details

About Us

Suzhou Porton Biologics Ltd. always adheres to the service concept of “customer first”. We take full advantage of the state-of-art technology and equipment and create high-standard biological drug CRO and CDMO platforms. We are committed to providing robust and fast services to meet your CRO and CDMO needs in China and around the globe.

OUR COMPANY

OUR COMPANY

OUR TEAM

OUR TEAM

CORPORATE CULTURE

CORPORATE CULTURE

SOCIAL RESPONSIBLITY

SOCIAL RESPONSIBLITY

Company News

Portonbio announced strategic cooperation with KAEDI to accelerate the R&D and production of CAR-T drugs

Portonbio announced a strategic cooperation with KAEDI .Portonbio will offer CMC services for KAEDI’s CAR-T cell therapies with its end-to-end CDMO platform for gene and cell therapies to help accelerate their development process.

READ MORE

Porton Biologics Announces Closing Series-A Financing to Drive Commercial Production of Gene and Cell Therapy

On April 16, 2021, Suzhou Porton Biologics Ltd., which focuses on gene and cell therapy CDMO service, officially announced the closing of Series A funding round, which raised 400 million RMB. The participants of the financing include industry's top-tier investment institutions, SDIC and GL Ventures, HM Capital, Huashan Ruilian and Momentum Venture.

READ MORE

Porton Biologics will attend the BioPharmaceutical Innovation Technology Summit 2021

TheBioPharmaceuticalInnovationTechnologySummit2021willbeheldatCrownePlazaShanghaiPujiangon9-10th,April.OurboothnumberisD1.WelcometoattendtheconferenceandseminarsessiongivenbyPortonBiologics.

READ MORE

More
Contact Us

Business cooperation:BD.SZ@portonbio.com

If you have any questions or comments about our business, please fill in the form below and we will contact you as soon as possible.

Leave message